πŸ‡ΊπŸ‡Έ FDA
Patent

US 7645732

Treating hepatitis C virus infection

granted A61KA61K31/7056A61K38/21

Quick answer

US patent 7645732 (Treating hepatitis C virus infection) held by The Board of Regents of the University of Texas System expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/7056, A61K38/21, A61P, A61P31/12